Will 2016 Be Regeneron Pharmaceuticals Inc.'s Best Year Yet?
The company had planned on getting it into regulators' hands during 2015, but that didn't happen, so it's likely we'll see a submission early this year. Second is dupilumab, a potential treatment for eczema and asthma, which might also be able to find …
Read more on Motley Fool

How Vaseline Is Helping Syrian Refugees
Almost two years ago, when many people in the U.S. were still blindly unaware of what was really happening in Syria, two dermatologists, Grace Bandow, MD, and Samer Jaber, MD, went on a medical mission to the Syrian refugee camps in Jordan.
Read more on Refinery29